During the past decade, Special Immunizations Program/USAMRIID conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Special Immunizations Program/USAMRIID" are "Venezuelan Equine Encephalomyelitis" (1 trials) and "Western Equine Encephalitis" (1 trials). Many other conditions were trialed in "Special Immunizations Program/USAMRIID" in a lesser frequency.

Most popular intervention types in "Special Immunizations Program/USAMRIID" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1" (1 trials) and "Western Equine Encephalitis (WEE) Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Special Immunizations Program/USAMRIID" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Special Immunizations Program/USAMRIID". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Special Immunizations Program/USAMRIID, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Special Immunizations Program/USAMRIID, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".